Therefore, we envisioned that PAX8-PPARγ coupled with an ultrasound nanobubble contrast agent is needed to find a breakthrough point for early noninvasive diagnosis of thyroid cancer. This evidence concerns the gene PAX8 and thyroid gland carcinoma.